Falling rates of smoking are one of America’s greatest public health triumphs, with numbers dropping 20% since 2005 alone. Hence, it is widely known that for some time tobacco companies have focussed on international markets. For example, in China, men smoke at double the rate of those in the U.S. and in Russia the rate is nearly three times that of America. As more and more nations recognize the human and economic costs of tobacco use, international pressure is building against the U.S. companies who profit from smoking.
In “A Marlboro Vaccine? Maybe for China,” The Wall Street Journal Reports that cigarette giant Phillip Morris is trying to improve it’s image in China ” where more than a third of the world’s cigarettes are smoked. “In one curious effort, (Phillip Morris) is setting out to develop flu vaccines derived from a type of tobacco plant. Continue reading “Phillip Morris’s new remorse over China sales”